10 Cancers - 1 Sample of Blood - Unlimited Possibilities
Aristotle™ is our next generation test for simultaneously screening for ten cancers from a single sample of blood. Preliminary data shows we can fully discriminate and detect each cancer with high sensitivity and specificity.
GeneNews (TSX: GEN) is now StageZero Life Sciences. Our new ticker symbol is (TSX:SZLS)